Immuno-Oncology and Technology
| Format: | journal |
|---|---|
| Language: | English |
| Published: |
Elsevier
2021
|
| Subjects: | |
| Online Access: | https://doaj.org/toc/2590-0188 |
| id |
oai:doaj.org-journal:32b0bb5bf720430f8f67aa86c8aa3ab4 |
|---|---|
| record_format |
dspace |
| spelling |
oai:doaj.org-journal:32b0bb5bf720430f8f67aa86c8aa3ab42023-03-29T11:37:18ZImmuno-Oncology and Technology2590-0188https://doaj.org/toc/2590-0188ENCC BYCC BY-NC-NDElsevierhttps://www.elsevier.com/journals/immuno-oncology-and-technology/2590-0188/guide-for-authorshttps://www.elsevier.com/authors/open-access/choice#waivershttps://www.journals.elsevier.com/immuno-oncology-and-technologyhttps://www.elsevier.com/journals/immuno-oncology-and-technology/2590-0188/open-access-journal2021-10-19T08:25:52ZjournaloncologyimmunotherapyNeoplasms. Tumors. Oncology. Including cancer and carcinogensRC254-282 |
| institution |
DOAJ |
| collection |
DSpace |
| language |
English |
| topic |
oncology immunotherapy Neoplasms. Tumors. Oncology. Including cancer and carcinogens RC254-282 |
| spellingShingle |
oncology immunotherapy Neoplasms. Tumors. Oncology. Including cancer and carcinogens RC254-282 Immuno-Oncology and Technology |
| format |
journal |
| title |
Immuno-Oncology and Technology |
| title_short |
Immuno-Oncology and Technology |
| title_full |
Immuno-Oncology and Technology |
| title_fullStr |
Immuno-Oncology and Technology |
| title_full_unstemmed |
Immuno-Oncology and Technology |
| title_sort |
immuno-oncology and technology |
| publisher |
Elsevier |
| publishDate |
2021 |
| url |
https://doaj.org/toc/2590-0188 |
| _version_ |
1801185080798871552 |
